Feasibility of ex vivo gene therapy for neurological disorders using the new retroviral vector GCDNsap packaged in the vesicular stomatitis virus G protein

Journal of Neurochemistry

Volumn 82, Issue 4, 2002, Pages 953-960

  Suzuki, A ^a   Obi, K ^a   Urabe, T ^a   Hayakawa, H ^a   Yamada, M ^a   Kaneko, S ^b   Onodera, M ^c   Mizuno, Y ^a   Mochizuki, H ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b University of Tsukuba   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Gene therapy; Neuronal progenitor cell; Pseudo typed retroviral vector; Transplantation

Indexed keywords

ADENOVIRUS VECTOR; EPIDERMAL GROWTH FACTOR; GENE PRODUCT; GREEN FLUORESCENT PROTEIN; PROTEIN GCDNSAP; UNCLASSIFIED DRUG; VESICULAR STOMATITIS VIRUS G PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BRAIN REGION; CELL DIFFERENTIATION; CELL MATURATION; CELL RENEWAL; CONTROLLED STUDY; DNA MODIFICATION; FETAL CALF SERUM; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC ENGINEERING; GENETIC TRANSDUCTION; MALE; MOUSE; NERVE CELL; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; STEM CELL;

ANIMALS; CELLS, CULTURED; CLONE CELLS; CORPUS STRIATUM; FEASIBILITY STUDIES; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; GRAFT SURVIVAL; LUMINESCENT PROTEINS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; NERVOUS SYSTEM DISEASES; RETROVIRIDAE; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSDUCTION, GENETIC; VIRAL ENVELOPE PROTEINS;

ADENOVIRIDAE; ANIMALIA; UNIDENTIFIED RETROVIRUS; VESICULAR STOMATITIS VIRUS;

EID: 0036678957     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.01048.x     Document Type: Article

References (18)

1. Therapeutic potential of neurotrophic factors and neural stem cells against ischemic brain injury
2. Cell replacement therapies for central nervous system disorders
3. Two blocks in Moloney murine leukemia virus expression in undifferentiated F9 embryonal carcinoma cells as determined by transient expression assays
4. Negative control region at the 5′ end of murine leukemia virus long terminal repeats
5. Improved expression in hematopoietic and lymphoid cells in mice after transplantation of bone marrow transduced with a modified retroviral vector
6. Simplified retroviral vector gcsap with murine stem cell virus long terminal repeat allows high and continued expression of enhanced green fluorescent protein by human hematopoietic progenitors engrafted in nonobese diabetic/severe combined immunodeficient mice
7. Non-function of a Moloney murine leukaemia virus regulatory sequence in F9 embryonal carcinoma cells
8. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells
9. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes
10. Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes
11. Clonal and population analyses demon-strate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell
12. A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes
13. Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells
14. Generation of dopaminergic neurons in the adult brain from mesencephalic precursor cells labeled with a nestin-GFP transgene
15. Inhibition of VSV binding and infectivity by phosphatidylserine: Is phosphatidylserine a VSV-binding site?
16. Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinsons disease
17. Mechanism of suppression of the long terminal repeat of Moloney leukemia virus in mouse embryonal carcinoma cells
18. High-resolution analysis of cytosine methylation in the 5 long terminal repeat of retroviral vectors